Cargando…

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis

Lysophosphatidic acid (LPA) is a pleiotropic extracellular lipid mediator with many physiological functions that signal through six known G protein-coupled receptors (LPA(1–6)). In the central nervous system (CNS), LPA mediates a wide range of effects including neural progenitor cell physiology, neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puigdomenech-Poch, Maria, Martínez-Muriana, Anna, Andrés-Benito, Pol, Ferrer, Isidre, Chun, Jerold, López-Vales, Rubèn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026865/ https://www.ncbi.nlm.nih.gov/pubmed/33841099 http://dx.doi.org/10.3389/fncel.2021.600872

Ejemplares similares

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA(2)), UCM-14216, Ameliorates Spinal Cord Injury in Mice
por: Khiar-Fernández, Nora, et al.
Publicado: (2022)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés-Benito, Pol, et al.
Publicado: (2018)

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés‐Benito, Pol, et al.
Publicado: (2021)

Role of lysophosphatidic acid receptor LPA(2 )in the development of allergic airway inflammation in a murine model of asthma
por: Zhao, Yutong, et al.
Publicado: (2009)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice
por: Wang, Fang, et al.
Publicado: (2020)

Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding
por: Ray, Manisha, et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
por: McAlary, Luke, et al.
Publicado: (2020)

LPA(1), LPA(2), LPA(4), and LPA(6) receptor expression during mouse brain development
por: Suckau, Olga, et al.
Publicado: (2019)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Lysophosphatidic acid, LPA: a bad boy becomes good
por: Budnik, Lygia T
Publicado: (2003)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
por: Wocławek-Potocka, Izabela, et al.
Publicado: (2014)

CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves
por: Martínez-Muriana, Anna, et al.
Publicado: (2016)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis
por: Lachén-Montes, Mercedes, et al.
Publicado: (2020)

Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
por: Jagaraj, Cyril Jones, et al.
Publicado: (2021)

Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis
por: Andrés-Benito, Pol, et al.
Publicado: (2017)

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
por: Assialioui, Abdelilah, et al.
Publicado: (2022)

A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men
por: Martin, Sarah, et al.
Publicado: (2022)

An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model
por: Ma, Lin, et al.
Publicado: (2013)

Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
por: Paez-Colasante, Ximena, et al.
Publicado: (2020)

Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration?
por: Gross, Isabel, et al.
Publicado: (2019)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
por: Balijepalli, Pravita, et al.
Publicado: (2021)

Lysophosphatidic acid receptors LPA(4) and LPA(6) differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes
por: Hata, Erina, et al.
Publicado: (2016)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

Lysophosphatidic Acid Receptor 5 (LPA(5)) Knockout Ameliorates the Neuroinflammatory Response In Vivo and Modifies the Inflammatory and Metabolic Landscape of Primary Microglia In Vitro
por: Joshi, Lisha, et al.
Publicado: (2022)

Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)
por: Park, Eun Young, et al.
Publicado: (2012)

Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts
por: Cerutis, D. Roselyn, et al.
Publicado: (2014)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
por: Su, Pan, et al.
Publicado: (2022)

HPLC-MS/MS Oxylipin Analysis of Plasma from Amyotrophic Lateral Sclerosis Patients
por: Mastrogiovanni, Mauricio, et al.
Publicado: (2022)

Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis
por: Mirian, Ario, et al.
Publicado: (2022)

Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells
por: McDonald, Whitney S., et al.
Publicado: (2020)

Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration
por: Andrés-Benito, Pol, et al.
Publicado: (2017)

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP
por: Ferrer, Isidro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j3ksd4gaig0411j7nth6okh50f